Literature DB >> 11557238

Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure.

J Marín-García1, M J Goldenthal, G W Moe.   

Abstract

BACKGROUND: Previous studies have shown that marked changes in myocardial mitochondrial structure and function occur in human cardiac failure. To further understand the cellular events and to clarify their role in the pathology of cardiac failure, we have examined mitochondrial enzymatic function and peptide content, and mitochondrial DNA (mtDNA) integrity in a canine model of pacing-induced cardiac failure.
METHODS: Myocardium and skeletal muscle tissues were evaluated for levels of respiratory complex I-V and citrate synthase activities, large-scale mtDNA deletions as well as peptide content of specific mitochondrial enzyme subunits. Levels of circulating and cardiac tumor necrosis factor-alpha (TNF-alpha), and of total aldehyde content in left ventricle were also assessed.
RESULTS: Specific activity levels of complex III and V were significantly lower in both myocardial and skeletal muscle tissues of paced animals compared to controls. In contrast, activity levels of complex I, II, IV and citrate synthase were unchanged, as was the peptide content of specific mitochondrial enzyme subunits. Large-scale mtDNA deletions were found to be more likely present in myocardial tissue of paced as compared to control animals, albeit at a relatively low proportion of mtDNA molecules (<0.01% of wild-type). In addition, the reduction in complex III and V activities was correlated with elevated plasma and cardiac TNF-alpha levels. Significant increases in left ventricle aldehyde levels were also found.
CONCLUSIONS: Our data show reductions in specific mitochondrial respiratory enzyme activities in pacing-induced heart failure which is not likely due to overall decreases in mitochondrial number, or necrosis. Our findings suggest a role for mitochondrial dysfunction in the pathogenesis of cardiac failure and may indicate a commonality in the signaling for pacing-induced mitochondrial dysfunction in myocardial and skeletal muscle. Increased levels of TNF-alpha and oxidative stress appear to play a contributory role.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557238     DOI: 10.1016/s0008-6363(01)00368-6

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  51 in total

1.  Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria.

Authors:  Dao-Fu Dai; Tony Chen; Jonathan Wanagat; Michael Laflamme; David J Marcinek; Mary J Emond; Calvin P Ngo; Tomas A Prolla; Peter S Rabinovitch
Journal:  Aging Cell       Date:  2010-04-29       Impact factor: 9.304

Review 2.  Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury.

Authors:  Nina Kaludercic; Andrea Carpi; Roberta Menabò; Fabio Di Lisa; Nazareno Paolocci
Journal:  Biochim Biophys Acta       Date:  2010-09-24

Review 3.  Mitochondrial centrality in heart failure.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  Heart Fail Rev       Date:  2008-01-05       Impact factor: 4.214

Review 4.  New aspects of impaired mitochondrial function in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

5.  Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress.

Authors:  Dao-Fu Dai; Edward J Hsieh; Yonggang Liu; Tony Chen; Richard P Beyer; Michael T Chin; Michael J MacCoss; Peter S Rabinovitch
Journal:  Cardiovasc Res       Date:  2011-10-19       Impact factor: 10.787

Review 6.  Regulation of mitochondrial ATP synthase in cardiac pathophysiology.

Authors:  Qinqiang Long; Kevin Yang; Qinglin Yang
Journal:  Am J Cardiovasc Dis       Date:  2015-03-20

Review 7.  A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition.

Authors:  Ashish Gupta; Brian Houston
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

8.  Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion.

Authors:  Yong Seon Choi; Ana Barbosa Marcondes de Mattos; Dan Shao; Tao Li; Miranda Nabben; Maengjo Kim; Wang Wang; Rong Tian; Stephen C Kolwicz
Journal:  J Mol Cell Cardiol       Date:  2016-09-28       Impact factor: 5.000

9.  Selective downregulation of mitochondrial electron transport chain activity and increased oxidative stress in human atrial fibrillation.

Authors:  Larisa Emelyanova; Zain Ashary; Milanka Cosic; Ulugbek Negmadjanov; Gracious Ross; Farhan Rizvi; Susan Olet; David Kress; Jasbir Sra; A Jamil Tajik; Ekhson L Holmuhamedov; Yang Shi; Arshad Jahangir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

10.  Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling.

Authors:  Zhong Gao; Andreas S Barth; Deborah DiSilvestre; Fadi G Akar; Yanli Tian; Antti Tanskanen; David A Kass; Raimond L Winslow; Gordon F Tomaselli
Journal:  Physiol Genomics       Date:  2008-09-09       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.